The diminished power of the immune system in older adults is usually blamed on the aging process. A new study shows that decades of inhaled particulates due to air pollution also take a toll.
Early Columbia pioneers Dorothy Andersen, Paul di Sant’Agnese, and Wynne Sharples led efforts to discover and treat cystic fibrosis, creating a legacy of treatment that continues at CUIMC today.
Marcos Vidal Melo, an internationally renowned cardiopulmonary scientist and anesthesiologist, has joined Columbia as chief of the Division of Cardiothoracic Anesthesiology.
A transplant team at NewYork-Presbyterian and Columbia University Vagelos College of Physicians and Surgeons gave a young man with cystic fibrosis new hope with a triple-organ transplant.
Columbia researchers have developed a way to gently collect stem cells from the airways of infants in the hope of finding new ways to prevent respiratory diseases common in premature babies.
New data from Columbia and other ECMO centers throughout the world show that more than 60% of severe COVID-19 patients who receive ECMO, a heart-lung life support machine, survive.
A new study reveals how P. aeruginosa bacteria—which cause many deaths worldwide from pneumonia—commandeer our immune defenses to thrive inside the lungs.
A mismatch between airway and lung size may explain why some nonsmokers get COPD and some heavy smokers do not, according to a new study from Columbia University.
A new study shows that smoking even a few cigarettes a day is harmful to lungs and that former smokers continue to lose lung function at a faster rate than never-smokers for decades after quitting.
Long-term exposure to air pollution, especially ozone, is associated with the development of emphysema, researchers at Columbia and other universities have found.
A new study from Columbia researchers provides robust evidence to support a simple, fixed ratio threshold for diagnosing chronic obstructive pulmonary disease (COPD).